FDA Says “No” To Onexa

fda advisory FDA Says No To Onexa

It’s been touted as the first new prescription weight-loss pill in more than a decade. But, following a study, a FDA advisory panel, because of safety concerns, refused to back the pill called Onexa.  The panel said the pill could cause depression, memory loss and holds the potential for birth defects if millions of overweight or obese Americans use it.

Listen to the report here:

blog comments powered by Disqus
Get The App
Best 24 Hour Food Spots In Sacramento

Listen Live